Lyra Therapeutics, Inc. (LYRA) SEC filings
LYRA SEC filings moved a median of 0.00% by the close. LYRA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the LYRA overview →
61 measured LYRA SEC filing events.
Where these LYRA SEC filings landedvs 59 measured LYRA SEC filing reactions
| Middle 50% of LYRA SEC filing reactions | -4.11% to +2.74% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 LYRA SEC filing events with a measured close landed between -4.11% and +2.74%; 49% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Lyra Therapeutics, Inc. For: Apr 13 | SEC filing · Form 8-K | +14.65% | +21.91% | |
| Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC | Press release | +14.65% | +21.91% | |
| Form 8-K Lyra Therapeutics, Inc. For: Mar 31 | SEC filing · Form 8-K | +13.21% | +22.64% | |
| Form 10-K Lyra Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.02% | |
| Form EFFECT Lyra Therapeutics, Inc. | SEC filing · Form EFFECT | -13.54% | -16.91% | |
| Form POS AM Lyra Therapeutics, Inc. | SEC filing · Form POS | +0.00% | +0.04% | |
| Form S-8 POS Lyra Therapeutics, Inc. | SEC filing · Form S-8 | +0.00% | +0.04% | |
| Form 8-K Lyra Therapeutics, Inc. For: Mar 13 | SEC filing · Form 8-K | +13.00% | +61.29% | |
| Form 8-K Lyra Therapeutics, Inc. For: Feb 23 | SEC filing · Form 8-K | +1.02% | +22.68% | |
| Form 8-K Lyra Therapeutics, Inc. For: Feb 02 | SEC filing · Form 8-K | -7.10% | -16.94% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jan 09 | SEC filing · Form 8-K | +0.00% | +3.00% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.68% | — | |
| Form 8-K Lyra Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | -1.68% | — | |
| Form 8-K Lyra Therapeutics, Inc. For: Sep 04 | SEC filing · Form 8-K | — | -3.03% | |
| Form 8-K Lyra Therapeutics, Inc. For: Aug 20 | SEC filing · Form 8-K | -2.49% | -4.16% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +6.11% | |
| Form 8-K Lyra Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +0.00% | +6.11% | |
| Form 8-K Lyra Therapeutics, Inc. For: Aug 01 | SEC filing · Form 8-K | -0.98% | +0.74% | |
| Form EFFECT Lyra Therapeutics, Inc. | SEC filing · Form EFFECT | -0.44% | -4.29% | |
| Form S-1 Lyra Therapeutics, Inc. | SEC filing · Form S-1 | +0.00% | +2.44% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jun 26 | SEC filing · Form 8-K | +0.22% | -1.83% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | +1.48% | +13.20% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jun 09 | SEC filing · Form 8-K | -0.70% | -19.09% | |
| Form 8-K Lyra Therapeutics, Inc. For: May 27 | SEC filing · Form 8-K | +7.41% | -30.17% | |
| Form 8-K Lyra Therapeutics, Inc. For: May 14 | SEC filing · Form 8-K | -0.41% | +0.00% | |
| Form DEFA14A Lyra Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.84% | -3.88% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.09% | -4.11% | |
| Form 8-K Lyra Therapeutics, Inc. For: May 06 | SEC filing · Form 8-K | -0.09% | -4.11% | |
| Form DEF 14A Lyra Therapeutics, Inc. For: May 14 | SEC filing · Form DEF | +0.37% | +12.50% | |
| Form DEFA14A Lyra Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.37% | +12.50% | |
| Form PRE 14A Lyra Therapeutics, Inc. For: May 14 | SEC filing · Form PRE | -3.07% | -2.32% | |
| Form 10-K Lyra Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.59% | +0.88% | |
| Form 8-K Lyra Therapeutics, Inc. For: Mar 13 | SEC filing · Form 8-K | +0.59% | +0.88% | |
| Form S-8 Lyra Therapeutics, Inc. | SEC filing · Form S-8 | +0.59% | +0.88% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jan 10 | SEC filing · Form 8-K | -1.46% | -2.50% | |
| Form 8-K Lyra Therapeutics, Inc. For: Dec 12 | SEC filing · Form 8-K | +2.12% | +0.81% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.21% | -25.40% | |
| Form 8-K Lyra Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | -1.21% | -25.40% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.63% | +0.66% | |
| Form 8-K Lyra Therapeutics, Inc. For: Aug 14 | SEC filing · Form 8-K | +1.63% | +0.66% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jul 19 | SEC filing · Form 8-K | +2.41% | -0.21% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jun 13 | SEC filing · Form 8-K | -1.25% | -0.91% | |
| Form 8-K/A Lyra Therapeutics, Inc. For: May 16 | SEC filing · Form 8-K | +1.02% | -0.67% | |
| Form 8-K Lyra Therapeutics, Inc. For: May 16 | SEC filing · Form 8-K | -4.14% | -10.34% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.39% | +4.37% | |
| Form 8-K Lyra Therapeutics, Inc. For: Apr 30 | SEC filing · Form 8-K | +2.39% | +4.37% | |
| Form DEF 14A Lyra Therapeutics, Inc. For: Jun 13 | SEC filing · Form DEF | +0.85% | +9.09% | |
| Form DEFA14A Lyra Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.85% | +9.09% | |
| Form 8-K Lyra Therapeutics, Inc. For: Apr 15 | SEC filing · Form 8-K | -1.15% | +0.19% | |
| Form PRE 14A Lyra Therapeutics, Inc. For: Jun 13 | SEC filing · Form PRE | -1.15% | +0.19% | |
| Form EFFECT Lyra Therapeutics, Inc. | SEC filing · Form EFFECT | -0.57% | -9.08% | |
| Form 10-K Lyra Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -7.60% | -7.00% | |
| Form S-3 Lyra Therapeutics, Inc. | SEC filing · Form S-3 | -7.60% | -7.00% | |
| Form S-8 Lyra Therapeutics, Inc. | SEC filing · Form S-8 | -7.60% | -7.00% | |
| Form 8-K Lyra Therapeutics, Inc. For: Mar 21 | SEC filing · Form 8-K | -7.60% | -7.00% | |
| Form 8-K Lyra Therapeutics, Inc. For: Feb 26 | SEC filing · Form 8-K | -0.17% | -0.52% | |
| Form 8-K Lyra Therapeutics, Inc. For: Jan 08 | SEC filing · Form 8-K | +0.90% | +2.48% | |
| Form 8-K Lyra Therapeutics, Inc. For: Dec 21 | SEC filing · Form 8-K | -0.13% | -1.97% | |
| Form 8-K Lyra Therapeutics, Inc. For: Dec 14 | SEC filing · Form 8-K | +0.78% | -3.29% | |
| Form 10-Q Lyra Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.67% | -2.33% | |
| Form 8-K Lyra Therapeutics, Inc. For: Nov 07 | SEC filing · Form 8-K | -4.67% | -2.33% |
Keep exploring
More LYRA: earnings → · analyst actions → · LYRA overview →